Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

[Stability of NT-ProBNP in patients with systolic heart failure].

Jiménez-Navarro MF, Fernández-Moyano MA, Domínguez-Franco A, Gómez-Doblas JJ, Molero E, Gómez-Hernández G, Morell M, De Teresa-Galván E.

Rev Esp Cardiol. 2006 Oct;59(10):1075-8. Spanish.

2.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

3.

Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables.

Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Slottje K, Katus HA, Zugck C.

Clin Chem. 2009 May;55(5):923-9. doi: 10.1373/clinchem.2008.112052. Epub 2009 Mar 19.

4.

NT-proBNP in monitoring treatment of patients with congestive heart failure.

Al-Meslmani BM, Fahoum SK, Shamia MG.

Clin Lab. 2007;53(1-2):35-9.

PMID:
17323823
6.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
7.

Changes in B-type natriuretic peptides after surgical ventricular restoration.

Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D.

Eur J Cardiothorac Surg. 2007 May;31(5):922-8. Epub 2007 Feb 23.

PMID:
17321144
8.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F.

J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65.

9.
10.

NT-proBNP, IGF-I and survival in patients with chronic heart failure.

Petretta M, Colao A, Sardu C, Scopacasa F, Marzullo P, Pivonello R, Fontanella L, de Caterina M, de Simone A, Bonaduce D.

Growth Horm IGF Res. 2007 Aug;17(4):288-96. Epub 2007 Mar 23.

PMID:
17383209
11.
12.
13.

Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.

Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS.

Clin Chem. 2009 Jan;55(1):78-84. doi: 10.1373/clinchem.2008.108928. Epub 2008 Nov 21.

14.

Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.

Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M.

Kardiol Pol. 2008 Jul;66(7):750-5; discussion 756-7.

PMID:
18690566
15.

Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.

Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.

Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.

PMID:
18678308
16.

Probrain natriuretic peptide for assessment of efficacy in heart failure treatment.

Ozkara A, Turgut F, Selcoki Y, Karanfil A, Metin MR, Kanbay M, Tekin O, Akcay A.

Adv Ther. 2007 Nov-Dec;24(6):1233-9.

PMID:
18165205
17.

[Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].

Yang CL, Qiu YR, Zhou F, Feng PF.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):866-9. Chinese.

18.

Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.

Chong AY, Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY.

Int J Cardiol. 2007 Jun 25;119(1):80-2. Epub 2006 Oct 5.

PMID:
17027106
19.

Natriuretic peptide system is not exhausted in severe heart failure.

Lourenço P, Azevedo A, Araújo JP, Bettencourt P.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):39-43.

PMID:
19708225
20.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

Supplemental Content

Support Center